Acucela Inc. To Hold 2015 Annual Meeting Of Shareholders On June 8, 2015
Acucela Inc. (TOKYO: 4589), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, today announced that its 2015 Annual Meeting of Shareholders will be held on Monday, June 8, 2015 at Acucela’s headquarters in Seattle, Washington, at 1:00PM Pacific Time for shareholders of record as of March 31, 2015.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.